Andrew Dahl reports tax withholding on shares at EW
By AlphaYouPublished Form 4
Dahl Andrew M.
Reporting filer
Andrew Dahl reports tax withholding on shares, not an open-market purchase or sale, in Edwards Lifesciences Corp. Form 4 filed Nov 14, 2026 lists 1 entry.
- Disclosed
- Nov 14, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Dahl Andrew M. | 2026-11-13 | F | Tax/exercise withholding | 101.0000 | 105.8000 | 14,605.778 | 1 day | Filed terms
|
Common Stock
- Owner
- Dahl Andrew M.
- Date
- 2026-11-13
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 101.0000
- Price
- 105.8000
- Following holdings
- 14,605.778
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-13
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- id: F1
- transaction Shares: 101.0000
- transaction Price Per Share: 105.8000
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 14605.7777
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Dahl Andrew M.: SVP, Corporate Controller.
- F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Original sources
Prepared automatically from public filing data. Report a correction.